Top 5 Revenue Growth by Industry Top Five Revenue: Major Drug Manufacturers 5/18/10 Welcome to our Top 5 Revenue page, which lists the top stocks based on Revenue Growth in certain industries each week. This week we look at Major Drug Manufacturers. Only U.S. companies are shown. Growth rates are calculated on the trailing twelve month period. These stocks are taken from a screening program and are not recommended to buy or sell. Further investigation is most appropriate before acting on this information.
INDUSTRY: Major Drug Manufacturers | | Company Name | Ticker | Revenue
Growth | Size | | | Glaxosmithkline | GSK | 16.5% | $90B | | | Merck & Co. | MRK | 15.0% | $102B | | | Eli Lilly & Co. | LLY | 7.2% | $39B | | | Sanofi Aventis | SNY | 6.7% | $79B | | | Bristol-Myers Squibb | BMY | 6.2% | $41B |
DISCLAIMER: Information has been obtained from sources deemed to be reliable, but The Online Investor makes no guarantee as to the accuracy or completeness of this data. Information is provided for informational purposes only, and The Online Investor shall not be liable for any errors or omissions, or for any actions taken in reliance thereon. |
Weekly Newsletter
printer-friendly format